Myomo
MYO on NYSEAmerican. Market value $66m.
Should I look at this?
We have not checked this company yet
This is not advice.
Who owns it
None of the long-term investors we follow own it. 80 funds in all.
Largest holders overall
- Rosalind Advisors$4mCut
- Vanguard Capital Management$2mAdded
- AQR Capital Management$965,397Added
- Jefferies Financial Group$732,446
- Jane Street Group$620,206New
- Clearstead Advisors$442,635
- UBS Group AG$430,227Added
- Geode Capital Management$358,309Cut
- LPL Financial$320,320
- Palumbo Wealth Management$311,768New
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
2 investors own more than 5%; 1 of them is pushing for change.
- Rosalind Advisors, Inc.Passive investorat least 9.9%0.0 pts(filed with 3 related holders)Since 30 June 2026
- Horton Capital Partners Fund, LPActivistat least 6.0%+0.9 pts(filed with 3 related holders)Since 9 May 2026
What they said
The Reporting Persons purchased the Shares based on the Reporting Persons' belief that the Shares, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the…
Read the filing - Orin HirschmanPassive investorSold down below 5%Since 30 September 2025
| Holder | Stake | Since | |
|---|---|---|---|
Rosalind Advisors, Inc. Passive investor | at least 9.9%0.0 pts (filed with 3 related holders) | 30 June 2026 | |
Horton Capital Partners Fund, LP Activist | at least 6.0%+0.9 pts (filed with 3 related holders) | 9 May 2026 | What they saidThe Reporting Persons purchased the Shares based on the Reporting Persons' belief that the Shares, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the… Read the filing |
Orin Hirschman Passive investor | Sold down below 5% | 30 September 2025 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
In the last 12 months, 4 insiders bought $442,540 of shares on the open market. 3 sold $180,992.
- Kovelman HarryChief Medical OfficerSold
- Date
- 11 September 2026
- Shares
- 15,488
- Price
- $1.27
- Value
- $19,684
- Morris Milton MayoDirectorSold
- Date
- 2 September 2026
- Shares
- 15,000
- Price
- $1.41
- Value
- $21,150
- Kovelman HarryChief Medical OfficerSold
- Date
- 20 August 2026
- Shares
- 17,500
- Price
- $1.73
- Value
- $30,329
- KIRK THOMAS FDirectorBought
- Date
- 5 June 2026
- Shares
- 40,002
- Price
- $1.27
- Value
- $50,803
- KIRK THOMAS FDirectorBought
- Date
- 28 May 2026
- Shares
- 25,000
- Price
- $0.99
- Value
- $24,750
- Kovelman HarryChief Medical OfficerSold
- Date
- 28 May 2026
- Shares
- 11,536
- Price
- $1.02
- Value
- $11,767
- Kovelman HarryChief Medical OfficerSold
- Date
- 27 May 2026
- Shares
- 20,464
- Price
- $1.00
- Value
- $20,464
- KIRK THOMAS FDirectorBought
- Date
- 18 May 2026
- Shares
- 43,401
- Price
- $0.91
- Value
- $39,495
- Manko Joseph M. Jr.DirectorBought
- Date
- 15 May 2026
- Shares
- 30,367
- Price
- $0.89
- Value
- $27,027
- KIRK THOMAS FDirectorBought
- Date
- 15 May 2026
- Shares
- 31,605
- Price
- $0.91
- Value
- $28,761
| Date | Who | Did | Shares | Price | Value |
|---|---|---|---|---|---|
| 11 September 2026 | Kovelman Harry Chief Medical Officer | Sold | 15,488 | $1.27 | $19,684 |
| 2 September 2026 | Morris Milton Mayo Director | Sold | 15,000 | $1.41 | $21,150 |
| 20 August 2026 | Kovelman Harry Chief Medical Officer | Sold | 17,500 | $1.73 | $30,329 |
| 5 June 2026 | KIRK THOMAS F Director | Bought | 40,002 | $1.27 | $50,803 |
| 28 May 2026 | KIRK THOMAS F Director | Bought | 25,000 | $0.99 | $24,750 |
| 28 May 2026 | Kovelman Harry Chief Medical Officer | Sold | 11,536 | $1.02 | $11,767 |
| 27 May 2026 | Kovelman Harry Chief Medical Officer | Sold | 20,464 | $1.00 | $20,464 |
| 18 May 2026 | KIRK THOMAS F Director | Bought | 43,401 | $0.91 | $39,495 |
| 15 May 2026 | Manko Joseph M. Jr. Director | Bought | 30,367 | $0.89 | $27,027 |
| 15 May 2026 | KIRK THOMAS F Director | Bought | 31,605 | $0.91 | $28,761 |
From Form 4 filings: insiders must report trades in their own company's shares within two days.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
None of the warning signs we check for were found.
We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.
We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 9 Mar 2026, plus the 10-Q filed 5 Aug 2026 and 5 later 8-Ks.
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.